-
Issue 27/2013 - Significant progress in bioacrylic processes
Time of Update: 2022-11-12
(Lian Meng) Significant progress has been made in the bio-acrylic processBASF of Germany, Cargill of the United States and Novozymes of Denmark have announced significant progress in the process of acrylic acid, a renewable raw material jointly developed by the three parties, which has been successfully used in the small batch production of 3-hydroxypropionic acid (3-HP).
-
Issue 27/2013 - Progress in the production technology of rare earth isoprene rubber in China
Time of Update: 2022-11-12
Progress in the production technology of rare earth isoprene rubber in China■ Yan FengIsoprene rubber (IR, referred to as isoprene rubber) is a synthetic rubber prepared by solution polymerization of
-
It is expected to change the treatment model of first-line lymphoma Roche ADC combination reduces the risk of disease progression by 27%
Time of Update: 2021-12-28
On December 14, 2021, Genentech, a Roche subsidiary, announced that the "first-in-class" CD79b-targeted antibody-conjugated drug (ADC) Polivy (polatuzumab vedotin) will be linked to a treatment program called R-CHP It has been used in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL) in Phase 3 clinical trials with positive results .
-
Esophageal cancer is making great progress! Mercadon Keytruda (Corida) and chemotherapy first-line
Time of Update: 2020-10-06
currently, Keytruda has been approved in the United States, China, and Japan as a single-drug therapy for patients with relapsed localized advanced or metastatic esophageal squamous cell carcinoma with a second-line treatment tumor expression PD-L1 (combined positive score (CPS) of 10).